Authors:
Turlakow, A
Yeung, HWD
Pui, J
Macapinlac, H
Liebovitz, E
Rusch, V
Goy, A
Larson, SM
Citation: A. Turlakow et al., Fludeoxyglucose positron emission tomography in the diagnosis of giant cell arteritis, ARCH IN MED, 161(7), 2001, pp. 1003-1007
Authors:
Wang, WP
Larson, SM
Fazzari, M
Tickoo, SK
Kolbert, K
Sgouros, G
Yeung, H
Macapinlac, H
Rosai, J
Robbins, RJ
Citation: Wp. Wang et al., Prognostic value of [F-18]fluorodeoxyglucose positron emission tomographicscanning in patients with thyroid cancer, J CLIN END, 85(3), 2000, pp. 1107-1113
Authors:
Guillem, JG
Puig-La Calle, J
Akhurst, T
Tickoo, S
Ruo, L
Minsky, BD
Gollub, MJ
Klimstra, DS
Mazumdar, M
Paty, PB
Macapinlac, H
Yeung, H
Saltz, L
Finn, RD
Erdi, Y
Humm, J
Cohen, AM
Larson, S
Citation: Jg. Guillem et al., Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography, DIS COL REC, 43(1), 2000, pp. 18-24
Authors:
Wang, WP
Macapinlac, H
Larson, SM
Yeh, SDJ
Akhurst, T
Finn, RD
Rosai, J
Robbins, RJ
Citation: Wp. Wang et al., [F-18]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic I-131 whole body scans and elevated serum thyroglobulin levels, J CLIN END, 84(7), 1999, pp. 2291-2302
Authors:
Fong, YM
Saldinger, PF
Akhurst, T
Macapinlac, H
Yeung, H
Finn, RD
Cohen, A
Kemeny, N
Blumgart, LH
Larson, SM
Citation: Ym. Fong et al., Utility of F-18-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases, AM J SURG, 178(4), 1999, pp. 282-287